Published in:
Open Access
01-12-2022 | Amphotericin B | Case report
Aureobasidium melanigenum catheter-related bloodstream infection: a case report
Authors:
Shinya Yamamoto, Mahoko Ikeda, Yuki Ohama, Tomohiro Sunouchi, Yasutaka Hoshino, Hiroshi Ito, Marie Yamashita, Yoshiaki Kanno, Koh Okamoto, Satoshi Yamagoe, Yoshitsugu Miyazaki, Shu Okugawa, Jun Fujishiro, Kyoji Moriya
Published in:
BMC Infectious Diseases
|
Issue 1/2022
Login to get access
Abstract
Background
Aureobasidium melanigenum is a ubiquitous dematiaceous fungus that rarely causes invasive human infections. Here, we present a case of Aureobasidium melanigenum bloodstream infection in a 20-year-old man with long-term catheter use.
Case presentation
A 20-year-old man receiving home care with severe disabilities due to cerebral palsy and short bowel syndrome, resulting in long-term central venous catheter use, was referred to our hospital with a fever. After the detection of yeast-like cells in blood cultures on day 3, antifungal therapy was initiated. Two identification tests performed at a clinical microbiological laboratory showed different identification results: Aureobasidium pullulans from matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and Cryptococcus albidus from a VITEK2 system. Therefore, we changed the antifungal drug to liposomal amphotericin B. The fungus was identified as A. melanigenum by DNA sequence-based analysis. The patient recovered with antifungal therapy and long-term catheter removal.
Conclusion
It is difficult to correctly identify A. melanigenum by routine microbiological testing. Clinicians must pay attention to the process of identification of yeast-like cells and retain A. melanigenum in cases of refractory fungal infection.